Headquarters
USA

Organon

Organon is primarily engaged in manufacturing, fabricating or processing drugs in pharmaceutical preparations for human or veterinary use. Its products consist of pharmaceutical preparations promoted primarily to the dental, medical or veterinary professions, and pharmaceutical preparations mostly for the public. Organon has a market value of $6.89 billion. Specifically, Organon focuses on women’s health, biosimilars and established medicines. Organon has more than 60 medicines and other products in areas including reproductive health, heart disease, dermatology, allergies and asthma. It has an international footprint that serves people in more than 140 markets.

访问 Organon 网站

关于我们

加入我们

  • 登录
  • 成为我们的合作伙伴
  • 成为我们的会员
  • 订阅我们的新闻稿
  • 联系我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛